Article| Volume 80, ISSUE 8, P1490-1496, August 1997

Presence in Bovine Milk of Two Protease Inhibitors of the Plasmin System1

      This paper is only available as a PDF. To read, Please Download here.


      Proteolysis, caused by the serine proteinase plasmin (EC that is present in milk, influences the quality of dairy products. Within the plasmin system, activators and inhibitors control plasmin activity. This study investigated the presence in bovine milk of two serine proteinase inhibitors of the plasmin system, α2-antiplasmin and plasminogen activator inhibitor-1, and an isolation procedure used for partial purification of them from milk. Two colorimetric assays were used to detect either plasmin inhibitor activity or plasminogen activator inhibitor activity. Two inhibitors were partially purified from milk using a combination of ammonium sulfate fractionation and concanavalin A affinity chromatography. Plasminogen activator inhibitor-1 and α2-antiplasmin antigens, which were associated with the inhibitory activities from bovine milk, were visualized by Western blot using commercial polyclonal antibodies raised against the corresponding human inhibitors. Both inhibitors were present in milk as several forms, possibly from the formation of complexes with other milk proteins. The predominant forms of the inhibitors in milk exhibited an approximate molecular mass of 60 kDa for α2-antiplasmin and 55 kDa for plasminogen activator inhibitor-1.

      Key words

      Abbreviation key:

      α2-AP (α2-antiplasmin), Con A (concanavalin A), PA (plasminogen activator), PAI (plasminogen activator inhibitor), PI (plasmin inhibitor), rPAI (recombinant PAI)


        • Alessi M.C.
        • Declerck P.J.
        • De Mol M.
        • Nelles L.
        • Collen D.
        Purification and characterization of natural and recombinant human plasminogen activator inhibitor-1 (PAI-1).
        Eur. J. Biochem. 1988; 175: 531
        • Bastian E.D.
        • Hansen K.G.
        • Brown R.J.
        Inhibition of plasmin by β-lactoglobulin using casein and a synthetic substrate.
        J. Dairy Sci. 1993; 76: 3354
        • Christensen S.
        • Sottrup-Jensen L.
        Bovine α2-antiplasmin: N-terminal and reactive site sequence.
        FEBS Lett. 1992; 312: 100
        • Christensen S.
        • Wiegers T.
        • Hermansen J.
        • Sottrup-Jensen L.
        Plasma-derived protease inhibitors in bovine milk.
        Int. Dairy J. 1995; 5: 439
        • Farkye N.Y.
        • Landkammer C.F.
        Milk plasmin activity influence on Cheddar cheese quality during ripening.
        J. Food Sci. 1992; 57: 622
        • Heegaard C.W.
        • Rasmussen L.K.
        • Andreasen P.A.
        The plasminogen activation system in bovine milk: differential localization of tissue-type plasminogen activator and urokinase in milk fractions is caused by binding to casein and urokinase receptor.
        Biochim. Biophys. Acta. 1994; 1222: 45
        • Hekman C.M.
        • Loskutoff D.J.
        Bovine plasminogen activator inhibitor 1: specificity determinations and comparison of the active, latent and guanidine-activated forms.
        Biochemistry. 1988; 27: 2911
        • Honkanen-Buzalski T.
        • Sandholm M.
        Trypsininhibitors in mastitic milk and colostrum: correlation between trypsin-inhibitor capacity, bovine serum albumin and somatic cell contents.
        J. Dairy Res. 1981; 48: 213
        • Kohlmann K.L.
        • Nielsen S.S.
        • Ladisch M.R.
        Effects of a low concentration of added plasmin on ultra-high temperature processed milk.
        J. Dairy Sci. 1991; 74: 1151
        • Laemmli U.K.
        Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
        Nature (Lond.). 1970; 227: 680
        • Lawrence D.
        • Strandberg L.
        • Grundstrom T.
        • Ny T.
        Purification of active human plasminogen activator inhibitor 1 from Escherichia coli.
        Eur. J. Biochem. 1989; 186: 523
        • Levi M.
        • Roem D.
        • Kamp A.M.
        • de Boer J.P.
        • Hack C.E.
        • ten Cate J.W.
        Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo.
        Throm. Haemostasis. 1993; 69: 141
        • Lindberg T.
        Protease inhibitors in human milk.
        Pediatr. Res. 1979; 13: 969
        • Lindberg T.
        • Ohlsson K.
        • Weström B.
        Protease inhibitors and their relation to protease activity in human milk.
        Pediatr. Res. 1982; 16: 479
        • Lu D.D.
        • Nielsen S.S.
        Assays for native plasminogen activators in bovine milk.
        J. Dairy Sci. 1993; 76: 3362
        • Lu D.D.
        • Nielsen S.S.
        Isolation and characterization of native bovine milk plasminogen activators.
        J. Dairy Sci. 1993; 76: 3369
        • Moroi M.
        • Aoki N.
        Isolation and characterization of α2-plasmin inhibitor from human plasma: a novel proteinase inhibitor which inhibits activator-induced clot lysis.
        J. Biol. Chem. 1976; 251: 5956
        • Piñeiro A.
        • Ortega F.
        • Uriel J.
        Trypsin inhibitor from cow colostrum: isolation, electrophoretic characterization and immunologic properties.
        Biochim. Biophys. Acta. 1975; 379: 201
        • Richardson B.C.
        The proteinases of bovine milk and the effect of pasteurization on their activity.
        N. Z. J. Dairy Sci. Technol. 1983; 18: 233
        • van Mourik J.A.
        • Lawrence D.A.
        • Loskutoff D.J.
        Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells.
        J. Biol. Chem. 1984; 259: 14914
        • Weber B.A.
        • Nielsen S.S.
        Isolation and partial characterization of a native serine-type protease inhibitor from bovine milk.
        J. Dairy Sci. 1991; 74: 764
        • Wiman B.
        Affinity-chromatographic purification of human α2-antiplasmin.
        Biochem. J. 1980; 191: 229
        • Wiman B.
        Human α2-antiplasmin.
        Methods Enzymol. 1981; 80: 395
        • Wiman B.
        • Collen D.
        Purification and characterization of human antiplasmin, the fast-acting plasmin inhibitor in plasma.
        Eur. J. Biochem. 1977; 78: 19